Albert David Ltd
company logo

Albert David Ltd

ALBERTDAVD Share Price

BSE:524075

NSE:ALBERTDAVD

659.1

-3.85 (-0.58%)

As on April 6, 2026 at 04:14 PM
Loading chart...

Performance

Loading performance...

662.95

654.60

5240

0.35

10

Fundamentals

372.95Cr

38.81

0.95

0.02

16.83

0.77%

689.84

About

Albert David Limited (ADL), a Unit of Kothari Group, was incorporated in 1938 at Calcutta. The Company belongs to a renowned industrial house of Kolkata, the 'Kothari Group'. The Company's principal business is manufacturing and trading of Pharmaceutical Formulations, Infusion Solutions, Herbal Dosage Forms and Bulk Drugs by way of domestic sale or export. Apart from these, it manufactures disposable syringes and needles and a wide range of bulk drugs. It is recognised as a large IV fluid manufacturer, both in glass and polyethylene containers. ADL has entered into a technical collaboration with Morishita Pharmaceuticals, Japan, a subsidiary of Ajinomoto -- the world leader in amino acids -- to manufacture amino acid infusions, for which it came out with a rights issue in Aug.'87. It has also set up a new unit in Kalyani, West Bengal, to manufacture bulk drugs, which went on stream in 1990. Another rights issue in Mar.'90 augmented the long-term working capital. ADL has entered into technical collaboration with Pharma Plan, Germany, to supply machinery to manufacture 30 mln disposable syringes and 70 mln needles at Mandideep near Bhopal. ADL came up with a Rs 4.68-cr right issue to part finance the expansion of its capacity of IV fluids in plastic bottles (FFS technology) at Ghaziabad. During 1998-99, the company has developed some new products viz. Siozole Capsules and Ferrochelate-Z-Capsules with Iron & Zinc and folic acid in sustained released formulation. In 2002-03 the company has launched new products-INTECAR,NIMERIL-T,EVICT,ALROF-50. It is also planning to launch new products such as SIOOXY,ALAMIN FEZ,PANSURE. New products were launched such as - INTECAR Capsules, NIMERIL-T, EVICT, ALROF-50, ADLIN and SLOZIN during the year 2003; new products such as Alamin-FeZ and Pansure were introduced in 2004. SIOOXY (Anti-Oxidant with OMEGA-3 Fatty Acid) was launched in 2005, launched ALAMTN-Xtra, VERBET - the antivertigo drug and water for injection during year 2006; launched Antibiotic Azithromycin under brand 'AZ3' and expanded its Vision Care range (launched Antiglaucoma products, Antiinfectives, Irrigating Solution and Steroidal combinations) in 2009; launched uterine tonic-Siocare and Laxative combination-Evict Fibre and has also expanded its Anti-inflammatory & Analgesic range with launch of Anaflam XP in 2010; launched Rabeprazole and its combination (Anti-Peptic Ulcerant range) and Montelukast and its combination (Anti Asthmatic range) in 2013; launched Alamin Liquid and Alamin RLD (L-Arginine Sachet) in 2014; launched Dhup Tab & Drop (Vit.D3), Inbalanse-Z (probiotic) and Evict-XF (Laxative) in 2015; launched Sioneuron M/PG capsules, Inbalanse-Z capsules and Breaze-Fx tablet in 2017. It introduced two products i.e., Evacure and C3H in the market during year 2021-22.

1938

ALBERTDAVD

NameDesignation
A K KothariExecutive Chairman
Prabhawati Devi KothariNon Executive Director
Monjori MitraIndependent Director
Anand Vardhan KothariNon Executive Director
Anurag SinghiIndependent Director
Shourya SenguptaIndependent Director
Naresh PachisiaIndependent Director
Rajiv Anant DesaiAdditional Director

Albert David Ltd FAQs

How do I Buy Albert David Ltd Shares?

close

By opening a demat account and having your KYC papers confirmed online, you may simply purchase Albert David Ltd shares in BlinkX.

What is the Share Price of Albert David Ltd?

close

The share price of any stock is volatile and changes during the day due to a variety of variables. Albert David Ltd's share price is ₹659.1 as of 2026-04-06.

What is the PE ratio of Albert David Ltd?

close

Albert David Ltd's P/E ratio is 38.81 times as of 2026-04-06.

What is the PB ratio of Albert David Ltd?

close

Albert David Ltd's most recent financial reports indicate a price-to-book ratio of 0.95, showing the company's stock market valuation in relation to the value of its real assets.

What is the Market Cap of Albert David Ltd?

close

Market capitalization, often known as market cap, is the market value of all outstanding shares of a publicly listed corporation. Albert David Ltd's market capitalization is ₹372.95 Cr as on 2026-04-06.

What is the ROE of Albert David Ltd?

close

The current financial records of Albert David Ltd show a 4.44% ROE, showing great financial performance and effective capital utilisation, making it a significant statistic for investors.

What is the Total Asset of Albert David Ltd?

close

According to Albert David Ltd's most recent financial filings, the company has a total asset value of ₹116.08, which includes current and non-current assets such as inventory, cash, properties, and equipment.

What is the 52-week high and Low of Albert David Ltd?

close

The 52-week high/low price of a Albert David Ltd stock is the highest and lowest price at which it has traded over that period (about one year) and is used as a technical indicator. Albert David Ltd's 52-week high and low as of 2026-04-06 are ₹957.5 and ₹579.9, respectively.